Denovo Biopharma
Sina Burrell has over 20 years of experience in the pharmaceutical industry. Sina began their career in 2000 as a Research Associate at CuraGen Corporation. In 2001, they joined MannKind Corporation, where they held various roles, including Senior Manager, Corporate Quality & GxP Auditing, Manager, Corporate Quality & GxP Auditing, Senior Compliance Specialist/Auditor, Compliance Specialist/Auditor, Group Leader, Analytical Chemistry, and Analytical Chemist. In 2015, they moved to Regulatory Compliance Consulting, where they worked as a Principal Consultant. In 2017, they became the Director, Quality Assurance GCP at Cidara Therapeutics. Currently, they are the Head of Quality Assurance at Denovo Biopharma.
Sina Burrell attended Fairfield University and earned a BS in Chemistry.
This person is not in any teams
Denovo Biopharma
Denovo Biopharma is a private San Diego-based biotech company, also operating in China, providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.